StockTipsArenaBeta

BUY Medplus Health Services Limited — Keynote Capitals

BUYMedplus Health Services Limited

byKeynote CapitalsHorizon: NA (inferred 1 year)6 Aug 2025via Institutional / Brokerage Research

Entry₹836.1Inferred
Target₹1,130
Total upside +35.15% (call closed)
Stop lossNot given
At expiry₹690.36 Aug 2026, 3:30 pm
Expired-17.44%
Follow Keynote Capitals for new calls(56% target hit, 142 closed calls)Get alertsWatch MEDPLUS for new buy/sell callsGet alertsSee 3 active Long-term calls on MEDPLUSSee 56 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 6 Aug 2026
0 supporting2 neutral5 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (2)

The Board of Directors has decided to keep in abeyance the implementation of CAPEX plans, including setting up a Food Park and a Concierge Health & Wellness Services Facility. The company expects no a

NSE · Outcome of Board Meeting·23 Jul · 2w ago

(opens in new tab)

Market Pulse: Key triggers to watch before the July 21 trading session

NewsCnbc-Tv18·20 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (5)

MedPlus Admits Staff Went 'A Little Overboard' Selling Private-Label Medicines

NewsNdtv-Profit·23 Jul · 2w ago

(opens in new tab)

MedPlus Health shares fall up to 18%, slip below IPO price, dragged by these factors

NewsCnbc-Tv18·22 Jul · 2w ago

(opens in new tab)

MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?

NewsEt-Markets·22 Jul · 2w ago

(opens in new tab)

MedPlus Shares Fall Over 17% After Q1 Net Profit Declines 21%

NewsNdtv-Profit·22 Jul · 2w ago

(opens in new tab)

MedPlus Health Q1 net profit falls 22% as margins decline despite 22% revenue growth

NewsCnbc-Tv18·21 Jul · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.